Last reviewed · How we verify

NCT07164820

The Effect of Su Jok Therapy on Pain During Heel LanceProcedure in Newborn

Not yet recruiting NA Last updated 18 September 2025
What this trial tests

NA trial testing Su Jok Application in Heel Lance Procedures in 66 participants. Not yet recruiting.

Timeline
1 October 2025
Primary endpoint
1 October 2026
1 September 2027

Quick facts

Lead sponsorAtaturk University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment66
Start date1 October 2025
Primary completion1 October 2026
Estimated completion1 September 2027
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ataturk University

Who can join

Adults 1 Day to 1 Week, any sex, with Heel Lance Procedures or Pain Management. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: To determine the effect of Su Jok therapy on pain levels during the heel lance procedure in newborns. The study will be conducted as a randomized controlled experimental trial with a pretest-posttest control group design. The heel lance procedure will be video recorded, and pain assessment will be performed independently by an experienced neonatal intensive care nurse with 7 years of clinical expertise and a neonatologist, using validated pain assessment scales.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Su Jok Application

Trials testing the same drug.

Other Ataturk University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07164820.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing